Publications

Major publications of pharmahungary:

2020

Brenner GB, Makkos A, Nagy CT, Onódi Z, Sayour NV, Gergely TG, Kiss B, Görbe A, Sághy É, Zádori ZS, Lázár B, Baranyai T, Varga RS, Husti Z, Varró A, Tóthfalusi L, Schulz R, Baczkó I, Giricz Z, Ferdinandy P.
Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion.
Cells. 2020 Feb 26;9(3):E551.

Ferdinandy P, Yoneda F, Muraoka S, Fürst S, Gyires K, Miklya I.
Geroprotection in the future. In memoriam of Joseph Knoll: The selegiline story continues.
Eur J Pharmacol. 2020 Feb 5;868:172793

van Esbroeck ACM, Varga ZV, Di X, van Rooden EJ, Tóth VE, Onódi Z, Kuśmierczyk M, Leszek P, Ferdinandy P, Hankemeier T, van der Stelt M, Pacher P.
Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system.
Pharmacol Res. 2020 Jan;151:104578.

Makkos A, Szántai Á, Pálóczi J, Pipis J, Kiss B, Poggi P, Ferdinandy P, Chatgilialoglu A, Görbe A.
A Comorbidity Model of Myocardial Ischemia/Reperfusion Injury and Hypercholesterolemia in Rat Cardiac Myocyte Cultures.
Front Physiol. 2020 Jan 9;10:1564

Marija Gredic, Isabel Blanco, Gabor Kovacs, Zsuzsanna Helyes, Péter Ferdinandy, Horst  Olschewski, Joan Albert Barberà, Norbert Weissmann
Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
Br J Pharmacol, 2020 Jan 23[Online ahead of print]

Péter Bencsik, Kamilla Gömöri, Tamara Szabados, Péter Sántha, Zsuzsanna Helyes, Gábor Jancsó, Péter Ferdinandy, Anikó Görbe
Myocardial Ischemia Reperfusion Injury and Cardioprotection in the Presence of Sensory Neuropathy: Therapeutic Options
Br J Pharmacol, 2020 Feb 14[Online ahead of print]

Schreckenberg R, Klein J, Kutsche HS, Schulz R, Gömöri K, Bencsik P, Benczik B, Ágg B, Sághy É, Ferdinandy P, Schlüter KD.

Ischaemic post-conditioning in rats: Responder and non-responder differ in transcriptome of mitochondrial proteins.

J Cell Mol Med. 2020 Apr 16. doi: 10.1111/jcmm.15209. Epub ahead of print

Sághy É, Vörös I, Ágg B, Kiss B, Koncsos G, Varga ZV, Görbe A, Giricz Z, Schulz R, Ferdinandy P.

Cardiac miRNA Expression and their mRNA Targets in a Rat Model of Prediabetes.

Int J Mol Sci. 2020 Mar 20;21(6):2128.

Parini P, Altucci L, Balligand JL, Baumbach PDJ, Ferdinandy P, Filetti S, Maron BM, Petrillo E, Silverman EK, Barabasi AL, Loscalzo J; International Network Medicine Consortium.

The Network Medicine Imperative and the Need for an International Network Medicine Consortium.

Am J Med. 2020 Apr 19:S0002-9343(20)30340-5. doi: 10.1016/j.amjmed.2020.03.034. Epub ahead of print.

Perrino C, Ferdinandy P, Bøtker HE, Brundel BJJM, Collins P, Davidson SM, den Ruijter HM, Engel FB, Gerdts E, Girao H, Gyöngyösi M, Hausenloy DJ, Lecour S, Madonna R, Marber M, Murphy E, Pesce M, Regitz-Zagrosek V, Sluijter JPG, Steffens S, Gollmann-Tepeköylü C, Van Laake LW, Van Linthout S, Schulz R, Ytrehus K.

Improving Translational Research in Sex-specific Effects of Comorbidities and Risk Factors in Ischemic Heart Disease and Cardioprotection: Position Paper and Recommendations of the ESC Working Group on Cellular Biology of the Heart.

Cardiovasc Res. 2020 Jun 2:cvaa155.

Giricz Z, Makkos A, Schreckenberg R, Pöling J, Lörchner H, Kiss K, Bencsik P, Braun T, Schulz R, Ferdinandy P, Schlüter KD.

Swiprosin-1/EFhD-2 Expression in Cardiac Remodeling and Post-Infarct Repair: Effect of Ischemic Conditioning.

Int J Mol Sci. 2020 May 9;21(9):3359.

Ruiz-Meana M, Bou-Teen D, Ferdinandy P, Gyongyosi M, Pesce M, Perrino C, Schulz R, Sluijter J, Tocchetti CG, Thum T, Madonna R.

Cardiomyocyte ageing and cardioprotection: Consensus Document from the ESC Working Groups Cell Biology of the Heart and Myocardial Function.

Cardiovasc Res. 2020 May 8:cvaa132.

Andreadou I, Schulz R, Papapetropoulos A, Turan B, Ytrehus K, Ferdinandy P, Daiber A, Di Lisa F.

The role of mitochondrial reactive oxygen species, NO and H2 S in ischaemia/reperfusion injury and cardioprotection.

J Cell Mol Med. 2020 Jun;24(12):6510-6522.

Madonna R, Doria V, Görbe A, Cocco N, Ferdinandy P, Geng YJ, Pierdomenico SD, De Caterina R.

Co-expression of glycosylated aquaporin-1 and transcription factor NFAT5 contributes to aortic stiffness in diabetic and atherosclerosis-prone mice.

J Cell Mol Med. 2020 Mar;24(5):2857-2865.

2019

Lukovic D, Gugerell A, Zlabinger K, Winkler J, Pavo N, Baranyai T, Giricz Z, Varga ZV, Riesenhuber M, Spannbauer A, Traxler D, Jakab A, Garamvölgyi R, Petnehazy Ö, Pils D, Tóth L, Schulz R, Ferdinandy P, Gyöngyösi M.
Transcriptional Alterations by Ischaemic Postconditioning in a Pig Infarction Model: Impact on Microvascular Protection.
Int J Mol Sci. 2019 Jan 15;20(2).

Nagel F, Santer D, Stojkovic S, Kaun C, Schaefer AK, Krššák M, Abraham D, Bencsik P, Ferdinandy P, Kenyeres E, Szabados T, Wojta J, Trescher K, Kiss A, Podesser BK.
The impact of age on cardiac function and extracellular matrix component expression in adverse post-infarction remodeling in mice.
Exp Gerontol. 2019 May;119:193-202.

Ágg B, Császár A, Szalay-Bekő M, Veres DV, Mizsei R, Ferdinandy P, Csermely P, Kovács IA.
The EntOptLayout Cytoscape plug-in for the efficient visualization of major protein complexes in protein-protein interaction and signalling networks.
Bioinformatics. 2019 Nov 1;35(21):4490-4492.

Hausenloy DJ, Chilian W, Crea F, Davidson SM, Ferdinandy P, Garcia-Dorado D, van Royen N, Schulz R, Heusch G.
The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.
Cardiovasc Res. 2019 Jun 1;115(7):1143-1155.

Horváth Á, Botz B, Kiss T, Csekő K, Kiss I, Felinger A, Szabados T, Kenyeres É, Bencsik P, Mócsai A, Ferdinandy P, Helyes Z.
Subantimicrobial Dose Doxycycline Worsens Chronic Arthritis-Induced Bone Microarchitectural Alterations in a Mouse Model: Role of Matrix Metalloproteinases?
Front Pharmacol. 2019 Mar 20;10:233.

Oláh A, Mátyás C, Kellermayer D, Ruppert M, Barta BA, Sayour AA, Török M, Koncsos G, Giricz Z, Ferdinandy P, Merkely B, Radovits T.
Sex Differences in Morphological and Functional Aspects of Exercise-Induced Cardiac Hypertrophy in a Rat Model.
Front Physiol. 2019 Jul 12;10:889.

Bencsik P, Kiss K, Ágg B, Baán JA, Ágoston G, Varga A, Gömöri K, Mendler L, Faragó N, Zvara Á, Sántha P, Puskás LG, Jancsó G, Ferdinandy P.
Sensory Neuropathy Affects Cardiac miRNA Expression Network Targeting IGF-1, SLC2a-12, EIF-4e, and ULK-2 mRNAs.
Int J Mol Sci. 2019 Feb 25;20(4).

Madonna R, Angelucci S, Di Giuseppe F, Doria V, Giricz Z, Görbe A, Ferdinandy P, De Caterina R.
Proteomic analysis of the secretome of adipose tissue-derived murine mesenchymal cells overexpressing telomerase and myocardin.
J Mol Cell Cardiol. 2019 Jun;131:171-186.

Grigorian Shamagian L, Madonna R, Taylor D, Climent AM, Prosper F, Bras-Rosario L, Bayes-Genis A, Ferdinandy P, Fernández-Avilés F, Izpisua Belmonte JC, Fuster V, Bolli R.
Perspectives on Directions and Priorities for Future Preclinical Studies in Regenerative Medicine.
Circ Res. 2019 Mar 15;124(6):938-951.

Davidson SM, Ferdinandy P, Andreadou I, Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM, Hausenloy DJ, Garcia-Dorado D; CARDIOPROTECTION COST Action (CA16225).
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week.
J Am Coll Cardiol. 2019 Jan 8;73(1):89-99.

Lázár B, Brenner GB, Makkos A, Balogh M, László SB, Al-Khrasani M, Hutka B, Bató E, Ostorházi E, Juhász J, Kemény Á, László T, Tiszlavicz L, Bihari Z, Giricz Z, Szabó D, Helyes Z, Ferdinandy P, Gyires K, Zádori ZS.
Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat.
Cells. 2019 Mar 15;8(3).

Tuboly E, Gáspár R, Ibor MO, Gömöri K, Kiss B, Strifler G, Hartmann P, Ferdinandy P, Bartekova M, Boros M, Görbe A.
L-Alpha-glycerylphosphorylcholine can be cytoprotective or cytotoxic in neonatal rat cardiac myocytes: a double-edged sword phenomenon.
Mol Cell Biochem. 2019 Oct;460(1-2):195-203

Madonna R, Balistreri CR, De Rosa S, Muscoli S, Selvaggio S, Selvaggio G, Ferdinandy P, De Caterina R.
Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease.
J Clin Med. 2019 Jan 16;8(1).

Andreadou I, Schulz R, Badimon L, Adameová A, Kleinbongard P, Lecour S, Nikolaou PE, Falcão-Pires I, Vilahur G, Woudberg N, Heusch G, Ferdinandy P.
Hyperlipidaemia and cardioprotection: Animal models for translational studies.
Br J Pharmacol. 2019 Nov 26.

Bukosza EN, Kaucsár T, Godó M, Lajtár E, Tod P, Koncsos G, Varga ZV, Baranyai T, Nguyen MT, Schachner H, Sőti C, Ferdinandy P, Giricz Z, Szénási G, Hamar P.
Glomerular Collagen Deposition and Lipocalin-2 Expression Are Early Signs of Renal Injury in Prediabetic Obese Rats.
Int J Mol Sci. 2019 Aug 30;20(17).

Madonna R, Van Laake LW, Botker HE, Davidson SM, De Caterina R, Engel FB, Eschenhagen T, Fernandez-Aviles F, Hausenloy DJ, Hulot JS, Lecour S, Leor J, Menasché P, Pesce M, Perrino C, Prunier F, Van Linthout S, Ytrehus K, Zimmermann WH, Ferdinandy P, Sluijter JPG.
ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure.
Cardiovasc Res. 2019 Mar 1;115(3):488-500.

Lajtai K, Nagy CT, Tarszabó R, Benkő R, Hadjadj L, Sziva RE, Gerszi D, Bányai B, Ferdinandy P, Nádasy GL, Giricz Z, Horváth EM, Várbíró S.
Effects of Vitamin D Deficiency on Proliferation and Autophagy of Ovarian and Liver Tissues in a Rat Model of Polycystic Ovary Syndrome.
Biomolecules. 2019 Sep 10;9(9).

Spannbauer A, Traxler D, Lukovic D, Zlabinger K, Winkler J, Gugerell A, Ferdinandy P, Hausenloy DJ, Pavo N, Emmert MY, Hoerstrup SP, Jakab A, Gyöngyösi M, Riesenhuber M.
Effect of Ischemic Preconditioning and Postconditioning on Exosome-Rich Fraction microRNA Levels, in Relation with Electrophysiological Parameters and Ventricular Arrhythmia in Experimental Closed-Chest Reperfused Myocardial Infarction.
Int J Mol Sci. 2019 Apr 30;20(9).

Poz D, De Falco E, Pisano C, Madonna R, Ferdinandy P, Balistreri CR.
Diagnostic and Prognostic Relevance of Red Blood Cell Distribution Width for Vascular Aging and Cardiovascular Diseases.
Rejuvenation Res. 2019 Apr;22(2):146-162.

Davidson SM, Andreadou I, Barile L, Birnbaum Y, Cabrera-Fuentes HA, Cohen MV, Downey JM, Girao H, Pagliaro P, Penna C, Pernow J, Preissner KT, Ferdinandy P.
Circulating blood cells and extracellular vesicles in acute cardioprotection.
Cardiovasc Res. 2019 Jun 1;115(7):1156-1166.

Gomes CPC, Ágg B, Andova A, Arslan S, Baker A, Barteková M, Beis D, Betsou F, Wettinger SB, Bugarski B, Condorelli G, Silva GJJD, Danilin S, de Gonzalo-Calvo D, Buil A, Carmo-Fonseca M, Enguita FJ, Felekkis K, Ferdinandy P, Gyöngyösi M, Hackl M, Karaduzovic-Hadziabdic K, Hellemans J, Heymans S, Hlavackova M, Hoydal MA, Jankovic A, Jusic A, Kardassis D, Kerkelä R, Kuster GM, Lakkisto P, Leszek P, Lustrek M, Maegdefessel L, Martelli F, Novella S, O’Brien T, Papaneophytou C, Pedrazzini T, Pinet F, Popescu O, Potočnjak I, Robinson E, Sasson S, Scholz M, Simionescu M, Stoll M, Varga ZV, Vinciguerra M, Xuereb A, Yilmaz MB, Emanueli C, Devaux Y, on behalf of the EU-CardioRNA COST Action (CA17129).
Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129.
Noncoding RNA. 2019 Mar 29;5(2).

Hausenloy DJ, Bøtker HE, Ferdinandy P, Heusch G, Ng GA, Redington A, Garcia-Dorado D.
Cardiac innervation in acute myocardial ischaemia/reperfusion injury and cardioprotection.
Cardiovasc Res. 2019 Jun 1;115(7):1167-1177

Ferdinandy P, Baczkó I, Bencsik P, Giricz Z, Görbe A, Pacher P, Varga ZV, Varró A, Schulz R.
Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications.
Eur Heart J. 2019 Jun 7;40(22):1771-1777.

2018

Sluijter JPG, Davidson SM, Boulanger CM, Buzás EI, de Kleijn DPV, Engel FB, Giricz Z, Hausenloy DJ, Kishore R, Lecour S, Leor J, Madonna R, Perrino C, Prunier F, Sahoo S, Schiffelers RM, Schulz R, Van Laake LW, Ytrehus K, Ferdinandy P.
Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.
Cardiovasc Res. 2018 Jan 1;114(1):19-34.

Gohar A, de Kleijn DPV, Hoes AW, Rutten FH, Hilfiker-Kleiner D, Ferdinandy P, Sluijter JPG, den Ruijter HM.
Vascular extracellular vesicles in comorbidities of heart failure with preserved ejection fraction in men and women: The hidden players. A mini review.
Vascul Pharmacol. 2018 Dec;111:1-6.

Schulz R, Ágg B, Ferdinandy P.
Survival pathways in cardiac conditioning: individual data vs. meta-analyses. What do we learn?
Basic Res Cardiol. 2017 Nov 21;113(1):4.

Nagy CT, Koncsos G, Varga ZV, Baranyai T, Tuza S, Kassai F, Ernyey AJ, Gyertyán I, Király K, Oláh A, Radovits T, Merkely B, Bukosza N, Szénási G, Hamar P, Mathé D, Szigeti K, Pelyhe C, Jelemenský M, Onódi Z, Helyes Z, Schulz R, Giricz Z, Ferdinandy P.
Selegiline reduces adiposity induced by high-fat, high-sucrose diet in male rats.
Br J Pharmacol. 2018 Sep;175(18):3713-3726.

Bøtker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femminò S, García-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuhäuser M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schlüter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G.
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.
Basic Res Cardiol. 2018 Aug 17;113(5):39.

Koncsos G, Varga ZV, Baranyai T, Ferdinandy P, Schulz R, Giricz Z, Boengler K.
Nagarse treatment of cardiac subsarcolemmal and interfibrillar mitochondria leads to artefacts in mitochondrial protein quantification.
J Pharmacol Toxicol Methods. 2018 May – Jun;91:50-58.

Varga ZV, Ágg B, Ferdinandy P.
miR-125b is a protectomiR: A rising star for acute cardioprotection.
J Mol Cell Cardiol. 2018 Feb;115:51-53

Ágg B, Baranyai T, Makkos A, Vető B, Faragó N, Zvara Á, Giricz Z, Veres DV, Csermely P, Arányi T, Puskás LG, Varga ZV, Ferdinandy P.
MicroRNA interactome analysis predicts post-transcriptional regulation of ADRB2 and PPP3R1 in the hypercholesterolemic myocardium.
Sci Rep. 2018 Jul 4;8(1):10134.

Heger J, Bornbaum J, Würfel A, Hill C, Brockmann N, Gáspár R, Pálóczi J, Varga ZV, Sárközy M, Bencsik P, Csont T, Török S, Kojonazarov B, Schermuly RT, Böngler K, Parahuleva M, Ferdinandy P, Schulz R, Euler G.
JDP2 overexpression provokes cardiac dysfunction in mice.
Sci Rep. 2018 May 16;8(1):7647

Onódi Z, Pelyhe C, Terézia Nagy C, Brenner GB, Almási L, Kittel Á, Manček-Keber M, Ferdinandy P, Buzás EI, Giricz Z.
Isolation of High-Purity Extracellular Vesicles by the Combination of Iodixanol Density Gradient Ultracentrifugation and Bind-Elute Chromatography From Blood Plasma.
Front Physiol. 2018 Oct 23;9:1479.

Sluijter JPG, Davidson SM, Boulanger CM, Buzás EI, de Kleijn DPV, Engel FB, Giricz Z, Hausenloy DJ, Kishore R, Lecour S, Leor J, Madonna R, Perrino C, Prunier F, Sahoo S, Schiffelers RM, Schulz R, Van Laake LW, Ytrehus K, Ferdinandy P.
Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.
Cardiovasc Res. 2018 Jan 1;114(1):19-34

Schiattarella GG, Madonna R, Van Linthout S, Thum T, Schulz R, Ferdinandy P, Perrino C.
Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities.
Vascul Pharmacol. 2018 Mar 14.

Poz D, De Falco E, Pisano C, Madonna R, Ferdinandy P, Balistreri CR.
Diagnostic and Prognostic Relevance of Red Blood Cell Distribution Width for Vascular Aging and Cardiovascular Diseases.
Rejuvenation Res. 2019 Apr;22(2):146-162.

Bencsik P, Kupai K, Görbe A, Kenyeres É, Varga ZV, Pálóczi J, Gáspár R, Kovács L, Weber L, Takács F, Hajdú I, Fabó G, Cseh S, Barna L, Csont T, Csonka C, Dormán G, Ferdinandy P.
Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection.
Front Pharmacol. 2018 Apr 5;9:296.

2017

Varga VZ., Bence Á., Ferdinandy P.
miR-125b is a protectomiR: A rising star for acute cardioprotection
J Mol Cell Cardiol. 2017 Dec 30. pii: S0022-2828(17)30366-8.

Schreckenberg R, Bencsik P, Weber M, Abdallah Y, Csonka C, Gömöri K, Kiss K, Pálóczi J, Pipis J, Sárközy M, Ferdinandy P, Schulz R, Schlüter KD.
Adverse Effects on β-Adrenergic Receptor Coupling: Ischemic Postconditioning Failed to Preserve Long-Term Cardiac Function.
J Am Heart Assoc. 2017 Dec 22;6(12).

Boengler K, Bencsik P, Palóczi J, Kiss K, Pipicz M, Pipis J, Ferdinandy P, Schlüter KD, Schulz R.
Lack of Contribution of p66shc and Its Mitochondrial Translocation to Ischemia-Reperfusion Injury and Cardioprotection by Ischemic Preconditioning.
Front Physiol. 2017 Oct 5;8:733.

Leybaert L, Lampe PD, Dhein S, Kwak BR, Ferdinandy P, Beyer EC, Laird DW, Naus CC, Green CR, Schulz R.
Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.
Pharmacol Rev. 2017 Oct;69(4):396-478.

Giricz Z, Varga ZV, Koncsos G, Nagy CT, Görbe A, Mentzer RM Jr, Gottlieb RA, Ferdinandy P.
Autophagosome formation is required for cardioprotection by chloramphenicol.
Life Sci. 2017 Oct 1;186:11-16.

Thielmann M, Sharma V, Al-Attar N, Bulluck H, Bisleri G, Bunge JJH, Czerny M, Ferdinandy P, Frey UH, Heusch G, Holfeld J, Kleinbongard P, Kunst G, Lang I, Lentini S, Madonna R, Meybohm P, Muneretto C, Obadia JF, Perrino C, Prunier F, Sluijter JPG, Van Laake LW, Sousa-Uva M, Hausenloy DJ.
ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery.
Eur Heart J. 2017 Aug 14;38(31):2392-2407.

Andreadou I, Iliodromitis EK, Lazou A, Görbe A, Giricz Z, Schulz R, Ferdinandy. P.

Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Br J Pharmacol. 2017 Jan 6.

Pavo N, Lukovic D, Zlabinger K, Lorant D, Goliasch G, Winkler J, Pils D, Auer K, Ankersmit HJ, Giricz Z, Sárközy M, Jakab A, Garamvölgyi R, Emmert MY, Hoerstrup SP, Hausenloy DJ, Ferdinandy P, Maurer G, Gyöngyösi M.
Intrinsic remote conditioning of the myocardium as a comprehensive cardiac response to ischemia and reperfusion.
Oncotarget. 2017 Jun 12;8(40):67227-67240.

Daiber A, Di Lisa F, Ferdinandy P.
Pharmacology of oxidative stress: translational opportunities.
Br J Pharmacol. 2017 Jun;174(12):1511-1513.

Hausenloy DJ, Garcia-Dorado D, Bøtker HE, Davidson SM, Downey J, Engel FB, Jennings R, Lecour S, Leor J, Madonna R, Ovize M, Perrino C, Prunier F, Schulz R, Sluijter JPG, Van Laake LW, Vinten-Johansen J, Yellon DM, Ytrehus K, Heusch G, Ferdinandy P.

Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.

Cardiovasc Res. 2017 May 1;113(6):564-585.

Baranyai T, Giricz Z, Varga ZV, Koncsos G, Lukovic D, Makkos A, Sárközy M, Pávó N, Jakab A, Czimbalmos C, Vágó H, Ruzsa Z, Tóth L, Garamvölgyi R, Merkely B, Schulz R, Gyöngyösi M, Ferdinandy P.

In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning,
postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature.

J Transl Med. 2017 Apr 1;15(1):67.

Szobi A, Gonçalvesová E, Varga ZV, Leszek P, Kuśmierczyk M, Hulman M, Kyselovič J, Ferdinandy P, Adameová A.

Analysis of necroptotic proteins in failing human hearts.

J Transl Med. 2017 Apr 28;15(1):86.

Schulz R, Ágg B, Ferdinandy P.
Survival pathways in cardiac conditioning: individual data vs. meta-analyses. What do we learn?
Basic Res Cardiol. 2017 Nov 21;113(1):4.

Bencsik P, Bartekova M, Görbe A, Kiss K, Pálóczi J, Radosinska J, Szűcs G, Ferdinandy P.
MMP Activity Detection in Zymograms.
Methods Mol Biol. 2017;1626:53-70

Kemény Á, Csekő K, Szitter I, Varga ZV, Bencsik P, Kiss K, Halmosi R, Deres L, Erős K, Perkecz A, Kereskai L, László T, Kiss T, Ferdinandy P, Helyes Z.
Integrative characterization of chronic cigarette smoke-induced cardiopulmonary comorbidities in a mouse model.
Environ Pollut. 2017 Oct;229:746-759.

Perrino C, Barabási AL, Condorelli G, Davidson SM, De Windt L, Dimmeler S, Engel FB, Hausenloy DJ, Hill JA, Van Laake LW, Lecour S, Leor J, Madonna R, Mayr M, Prunier F, Sluijter JP, Schulz R, Thum T, Ytrehus K, Ferdinandy P.

Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for
diagnosis and therapy of the ischemic heart?

Cardiovasc Res. 2017 Apr 29.

Baranyai T, Giricz Z, Varga ZV, Koncsos G, Lukovic D, Makkos A, Sárközy M, Pávó N, Jakab A, Czimbalmos C, Vágó H, Ruzsa Z, Tóth L, Garamvölgyi R, Merkely B, Schulz R, Gyöngyösi M, Ferdinandy P.
In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature.
J Transl Med. 2017 Apr 1;15(1):67.

Giricz Z, Koncsos G, Rajtík T, Varga ZV, Baranyai T, Csonka C, Szobi A, Adameová A, Gottlieb RA, Ferdinandy P.
Hypercholesterolemia downregulates autophagy in the rat heart.
Lipids Health Dis. 2017 Mar 23;16(1):60.

Perrino C, Barabási AL, Condorelli G, Davidson SM, De Windt L, Dimmeler S, Engel FB, Hausenloy DJ, Hill JA, Van Laake LW, Lecour S, Leor J, Madonna R, Mayr M, Prunier F, Sluijter JPG, Schulz R, Thum T, Ytrehus K, Ferdinandy P.
Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.
Cardiovasc Res. 2017 Jun 1;113(7):725-736.

Varga ZV, Pipicz M, Baán JA, Baranyai T, Koncsos G, Leszek P, Kuśmierczyk M, Sánchez-Cabo F, García-Pavía P, Brenner GJ, Giricz Z, Csont T, Mendler L, Lara-Pezzi E, Pacher P, Ferdinandy P.
Alternative Splicing of NOX4 in the Failing Human Heart.
Front Physiol. 2017 Nov 22;8:935.

2016

Rajtik T, Carnicka S, Szobi A, Giricz Z, O-Uchi J, Hassova V, Svec P, Ferdinandy P, Ravingerova T, Adameova A.
Oxidative activation of CaMKIIδ in acute myocardial ischemia/reperfusion injury: A role of angiotensin AT1 receptor-NOX2 signaling axis.
Eur J Pharmacol. 2016 Jan 15;771:114-22. doi: 10.1016/j.ejphar.2015.12.024. Epub 2015 Dec 13.

Di Lisa F, Giorgio M, Ferdinandy P, Schulz R.
New aspects of p66Shc in ischemia reperfusion injury and cardiovascular diseases.
Br J Pharmacol. 2016 Mar 15. doi: 10.1111/bph.13478. [Epub ahead of print]

Madonna R, Van Laake LW, Davidson SM, Engel FB, Hausenloy DJ, Lecour S, Leor J, Perrino C, Schulz R, Ytrehus K, Landmesser U, Mummery CL, Janssens S, Willerson J, Eschenhagen T, Ferdinandy P, Sluijter JP.
Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
Eur Heart J. 2016 Apr 7. pii: ehw113. [Epub ahead of print] Review.

Sárközy M, Szűcs G, Fekete V, Pipicz M, Éder K, Gáspár R, Sója A, Pipis J, Ferdinandy P, Csonka C, Csont T.
Transcriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki rats.
Cardiovasc Diabetol. 2016 Aug 5;15(1):110.

Brockhoff B, Schreckenberg R, Forst S, Heger J, Bencsik P, Kiss K, Ferdinandy P, Schulz R, Schlüter KD.
Effect of nitric oxide deficiency on the pulmonary PTHrP system.
J Cell Mol Med. 2016 Aug 31.

Kiss K, Csonka C, Pálóczi J, Pipis J, Görbe A, Kocsis GF, Murlasits Z, Sárközy M, Szűcs G, Holmes CP, Pan Y, Bhandari A, Csont T, Shamloo M, Woodburn KW, Ferdinandy P, Bencsik P.
Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats.
Pharmacol Res. 2016 Aug 10;113(Pt A):62-70.

2015

Schreckenberg R, Weber P, Cabrera-Fuentes HA, Steinert I, Preissner KT, Bencsik P, Sárközy M, Csonka C, Ferdinandy P, Schulz R, Schlüter KD.
Mechanism and consequences of the shift in cardiac arginine metabolism following ischaemia and reperfusion in rats.
Thromb Haemost. 2015 Mar;113(3):482-93

Baán JA, Varga ZV, Leszek P, Kuśmierczyk M, Baranyai T, Dux L, Ferdinandy P, Braun T, Mendler L.
Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study.
J Transl Med. 2015 Jan 16;13:1.

Csont T, Murlasits Z, Ménesi D, Kelemen JZ, Bencsik P, Pipicz M, Fekete V, Zvara Á, Puskás LG, Ferdinandy P.
Tissue-specific Gene Expression in Rat Hearts and Aortas in a Model of Vascular Nitrate Tolerance.
J Cardiovasc Pharmacol. 2015 May;65(5):485-93

Kirca M, Kleinbongard P, Soetkamp D, Heger J, Csonka C, Ferdinandy P, Schulz R.
Interaction between connexin 43 and nitric oxide synthase in mice heart mitochondria.
J Cell Mol Med. 2015 Apr;19(4):815-25.

Varga ZV, Giricz Z, Bencsik P, Madonna R, Gyöngyösi M, Schulz R, Mayr M, Thum T, Puskás LG, Ferdinandy P.
Functional genomics of cardioprotection by ischemic conditioning and the influence of comorbid conditions: implications in target identification.
Curr Drug Targets. 2015 Apr 27.

Bencsik P, Sasi V, Kiss K, Kupai K, Kolossváry M, Maurovich-Horvat P, Csont T, Ungi I, Merkely B, Ferdinandy P.
Serum lipids and cardiac function correlate with nitrotyrosine and MMP activity in coronary artery disease patients.
Eur J Clin Invest. 2015 May 5.

Madonna R, Cadeddu C, Deidda M, Giricz Z, Madeddu C, Mele D, Monte I, Novo G, Pagliaro P, Pepe A, Spallarossa P, Tocchetti CG, Varga ZV, Zito C, Geng YJ, Mercuro G, Ferdinandy P.
Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology.
Int J Cardiol. 2015 Jul 15;191:203-210.

Schreckenberg R, da Costa Rebelo M, Deten A, Weber M, Rohrbach S, Pipicz M, Csonka C, Ferdinandy P, Schulz R, Schlüter KD.
Specific Mechanisms underlying Right Heart Failure: The missing Upregulation of Superoxide Dismutase-2 and its decisive Role in Antioxidative Defense.
Antioxid Redox Signal. 2015 May 15.

Schulz R, Görge PM, Görbe A, Ferdinandy P, Lampe PD, Leybaert L.
Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.
Pharmacol Ther. 2015 Jun 11. pii: S0163-7258(15)00120-5.

Sárközy M, Szűcs G, Pipicz M, Zvara Á, Éder K, Fekete V, Szűcs C, Bárkányi J, Csonka C, Puskás LG, Kónya C, Ferdinandy P, Csont T.
The effect of a preparation of minerals, vitamins and trace elements on the cardiac gene expression pattern in male diabetic rats.
Cardiovasc Diabetol. 2015 Jun 28;14:85. doi: 10.1186/s12933-015-0248-6.

Görbe A, Eder A, Varga ZV, Pálóczi J, Hansen A, Ferdinandy P, Eschenhagen T.
Protection by the NO-Donor SNAP and BNP against Hypoxia/Reoxygenation in Rat Engineered Heart Tissue.
PLoS One. 2015 Jul 6;10(7):e0132186. doi: 10.1371/journal.pone.0132186. eCollection 2015.

Madonna R, Petrov L, Teberino MA, Manzoli L, Karam JP, Renna FV, Ferdinandy P, Montero-Menei CN, Ylä-Herttuala S, De Caterina R.
Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction.
Cardiovasc Res. 2015 Oct 1;108(1):39-49. doi: 10.1093/cvr/cvv197. Epub 2015 Jul 17.

Varga ZV, Ferdinandy P, Liaudet L, Pacher P.
Drug-induced mitochondrial dysfunction and cardiotoxicity.
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1453-67. doi: 10.1152/ajpheart.00554.2015. Epub 2015 Sep 18. Review.

Baranyai T, Nagy CT, Koncsos G, Onódi Z, Károlyi-Szabó M, Makkos A, Varga ZV, Ferdinandy P, Giricz Z.
Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning.
Cardiovasc Diabetol. 2015 Nov 18;14:151. doi: 10.1186/s12933-015-0313-1.

Baranyai T, Herczeg K, Onódi Z, Voszka I, Módos K, Marton N, Nagy G, Mäger I, Wood MJ, El Andaloussi S, Pálinkás Z, Kumar V, Nagy P, Kittel Á, Buzás EI, Ferdinandy P, Giricz Z.
Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods.
PLoS One. 2015 Dec 21;10(12):e0145686. doi: 10.1371/journal.pone.0145686. eCollection 2015.

2014

Rassaf T, Ferdinandy P, Schulz R.
Nitrite in Organ Protection.
Br J Pharmacol. 2014 Jan;171(1):1-11.

Csont T, Sárközy M, Sz Cs G, Sz Cs C, Bárkányi J, Bencsik P, Gáspár R, Földesi I, Csonka C, Kónya C, Ferdinandy P.
Effect of a multivitamin preparation supplemented with phytosterol on serum lipids and infarct size in rats fed with normal and high cholesterol diet.
Lipids Health Dis. 2013 Sep 25;12(1):138.

Görbe A, Varga ZV, Pálóczi J, Rungarunlert S, Klincumhom N, Pirity MK, Madonna R, Eschenhagen T, Dinnyés A, Csont T, Ferdinandy P.
Cytoprotection by the NO-Donor SNAP Against Ischemia/Reoxygenation Injury in Mouse Embryonic Stem Cell-Derived Cardiomyocytes.
Mol Biotechnol. 2014 Mar;56(3):258-64.

Csonka C, Kupai K, Bencsik P, Görbe A, Pálóczi J, Zvara A, Puskas LG, Csont T, Ferdinandy P.
Cholesterol-enriched diet inhibits cardioprotection by ATP-cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive potassium channel activators cromakalim and diazoxide.
Am J Physiol Heart Circ Physiol. 2014 Feb;306(3):H405-13.

Kadomatsu K, Bencsik P, Görbe A, Csonka C, Sakamoto K, Kishida S, Ferdinandy P.
Therapeutic Potential of Midkine in Cardiovascular Diseases.
Br J Pharmacol. 2014 Feb;171(4):936-44.

Bencsik P, Pálóczi J, Kocsis GF, Pipis J, Belecz I, Varga ZV, Csonka C, Görbe A, Csont T, Ferdinandy P.
Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective.
Pharmacol Res. 2014 Feb;80:36-42.

Csonka C, Szucs G, Varga-Orvos Z, Bencsik P, Csont T, Zvara Á, Puskás LG, Ferdinandy P.
Ischemic postconditioning alters the gene expression pattern of the ischemic heart.
Exp Biol Med (Maywood). 2014 Feb;239(2):141-50.

Giricz Z, Varga ZV, Baranyai T, Sipos P, Pálóczi K, Kittel Á, Buzás EI, Ferdinandy P.
Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles.
J Mol Cell Cardiol. 2014 Mar;68:75-8.

Varga ZV, Zvara A, Faragó N, Kocsis GF, Pipicz M, Gáspár R, Bencsik P, Görbe A, Csonka C, Puskas LG, Thum T, Csont T, Ferdinandy P.
MicroRNAs associated with ischemia/reperfusion injury and cardioprotection by ischemic pre- and postconditioning: ProtectomiRs.
Am J Physiol Heart Circ Physiol. 2014 May 23.

Andreadou I, Iliodromitis EK, Rassaf T, Schulz R, Papapetropoulos A, Ferdinandy P.
The role of gasotransmitters NO, H2 S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
Br J Pharmacol. 2014 Jun 12.

Csonka C, Páli T, Bencsik P, Görbe A, Ferdinandy P, Csont T.
Measurement of NO in biological samples.
Br J Pharmacol. 2014 Jul 2

Madonna R, Geng YJ, Shelat H, Ferdinandy P, De Caterina R.
High glucose-induced hyperosmolarity impacts proliferation, cytoskeleton remodeling and migration of human induced pluripotent stem cells via aquaporin-1.
Biochim Biophys Acta. 2014 Nov;1842(11):2266-75.

Sárközy M, Fekete V, Szűcs G, Török S, Szűcs C, Bárkányi J, Varga ZV, Földesi I, Csonka C, Kónya C, Csont T, Ferdinandy P.
Anti-diabetic effect of a preparation of vitamins, minerals and trace elements in diabetic rats: a gender difference.
BMC Endocr Disord. 2014 Aug 26;14:72.

Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R.
Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning.
Pharmacol Rev. 2014 Oct;66(4):1142-1174.

Pechánová O, Varga Z, Cebová M, Giricz Z, Pacher P, Ferdinandy P.
Cardiac Nitric Oxide Signalling in Metabolic Syndrome.
Br J Pharmacol. 2015 Mar;172(6):1415-33

Lecour S, Bøtker HE, Condorelli G, Davidson SM, Garcia-Dorado D, Engel FB, Ferdinandy P, Heusch G, Madonna R, Ovize M, Ruiz-Meana M, Schulz R, Sluijter JP, Van Laake LW, Yellon DM, Hausenloy DJ.
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies.
Cardiovasc Res. 2014 Dec 1;104(3):399-411.

Madonna R, Ferdinandy P, De Caterina R, Willerson JT, Marian AJ.
Recent developments in cardiovascular stem cells.
Circ Res. 2014 Dec 5;115(12):e71-8

2013

Monostori P, Kocsis GF, Okrös Z, Bencsik P, Czétényi O, Kiss Z, Gellén B, Bereczki C, Ocsovszki I, Pipis J, Pálóczi J, Sárközy M, Török S, Varga IS, Kiss I, Fodor E, Csont T, Ferdinandy P, Túri S.
Different administration schedules of darbepoetin alfa affect oxidized and reduced glutathione levels to a similar extent in 5/6 nephrectomized rats.
Clin Exp Nephrol. 2013 Aug;17(4):569-74.

Sárközy M, Zvara A, Gyémánt N, Fekete V, Kocsis GF, Pipis J, Szűcs G, Csonka C, Puskás LG, Ferdinandy P, Csont T.
Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats.
Cardiovasc Diabetol. 2013 Jan 15;12:16.

Hausenloy DJ, Erik Bøtker H, Condorelli G, Ferdinandy P, Garcia-Dorado D, Heusch G, Lecour S, van Laake LW, Madonna R, Ruiz-Meana M, Schulz R, Sluijter JP, Yellon DM, Ovize M.
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
Cardiovasc Res. 2013 Apr 1;98(1):7-27.

Hill C, Würfel A, Heger J, Meyering B, Schlüter KD, Weber M, Ferdinandy P, Aronheim A, Schulz R, Euler G.
Inhibition of AP-1 signaling by JDP2 overexpression protects cardiomyocytes against hypertrophy and apoptosis induction.
Cardiovasc Res. 2013 Jul 1;99(1):121-8.

Madonna R, Görbe A, Ferdinandy P, De Caterina R.
Glucose Metabolism, Hyperosmotic Stress, and Reprogramming of Somatic Cells.
Mol Biotechnol. 2013 Oct;55(2):169-78.

Fekete V, Murlasits Z, Aypar E, Bencsik P, Sárközy M, Szénási G, Ferdinandy P, Csont T.
Myocardial postconditioning is lost in vascular nitrate tolerance.
J Cardiovasc Pharmacol. 2013 Sep;62(3):298-303.

Szűcs G, Murlasits Z, Török S, Kocsis GF, Pálóczi J, Görbe A, Csont T, Csonka C, Ferdinandy P.
Cardioprotection by farnesol: role of the mevalonate pathway.
Cardiovasc Drugs Ther. 2013 Aug;27(4):269-77.

Varga ZV, Kupai K, Szűcs G, Gáspár R, Pálóczi J, Faragó N, Zvara A, Puskás LG, Rázga Z, Tiszlavicz L, Bencsik P, Görbe A, Csonka C, Ferdinandy P, Csont T.
MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart.
J Mol Cell Cardiol. 2013 Sep;62:111-21.

2012

Kocsis GF, Sárközy M, Bencsik P, Pipicz M, Varga ZV, Pálóczi J, Csonka C, Ferdinandy P, Csont T.
Preconditioning protects the heart in a prolonged uremic condition.
Am J Physiol Heart Circ Physiol. 303(10):H1229-36 (2012)

2011

Görbe A, Varga ZV, Kupai K, Bencsik P, Kocsis GF, Csont T, Boengler K, Schulz
R, Ferdinandy P.
Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43.
Am J Physiol Heart Circ Physiol. 300:H1907-13 (2011)

Szucs G, Bester DJ, Kupai K, Csont T, Csonka C, Esterhuyse AJ, Ferdinandy P, Van Rooyen J.
Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats.
Lipids Health Dis. 10:103 (2011)

2010

Csont T, Görbe A, Bereczki E, Szunyog A, Aypar E, Tóth ME, Varga ZV, Csonka C, Fülöp F, Sántha M, Ferdinandy P.
Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: Role of nitric oxide.
J Mol Cell Cardiol. 48:649-652 (2010)

Kupai K, Szucs G, Cseh S, Hajdu I, Csonka C, Csont T, Ferdinandy P.
Matrix metalloproteinase activity assays: Importance of zymography.
J Pharmacol Toxicol Methods. 61:205-209 (2010)

Csonka C, Kupai K, Kocsis GF, Novák G, Fekete V, Bencsik P, Csont T, Ferdinandy P.
Measurement of myocardial infarct size in preclinical studies.
J Pharmacol Toxicol Methods. 61:163-170 (2010)

Gorbe A, Giricz Z, Szunyog A, Csont T, Burley DS, Baxter GF, Ferdinandy P.
Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation.
Basic Res Cardiol. 105:643-650 (2010).

Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R.
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
Cardiovasc Res. 87:406-423 (2010).

Dormán G, Cseh S, Hajdú I, Barna L, Kónya D, Kupai K, Kovács L, Ferdinandy P.
Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.
Drugs. 70:949-964 (2010)

Bencsik P, Kupai K, Giricz Z, Görbe A, Pipis J, Murlasits Z, Kocsis GF, Varga-Orvos Z, Puskás LG, Csonka C, Csont T, Ferdinandy P.
Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
Am J Physiol Heart Circ Physiol. 299:H512-518 (2010)

2009

Kupai K, Csonka C, Fekete V, Odendaal L, van Rooyen J, Marais de W, Csont T, Ferdinandy P.
Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite.
Am J Physiol Heart Circ Physiol. 297:H1729-35 (2009)

2008

Kocsis GF, Pipis J, Fekete V, Kovacs-Simon A, Odendaal L, Molnar E, Giricz Z, Janaky T, van Rooyen J, Csont T, Ferdinandy P.
Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.
Am J Physiol Heart Circ Physiol 294:H2406-2409 (2008)

Csont T, Ferdinandy P.
Letter regarding article “Biglycan is required for adaptive remodeling after myocardial infarction”.
Circulation 118:e521 (2008)

2007

Bereczki E, Gonda S, Csont T, Korpos E, Zvara A, Ferdinandy P, Santha M.
Overexpression of biglycan in the heart of transgenic mice: an antibody microarray study.
J Proteome Res. 6:854-861(2007)

Papp A, Szommer T, Barna L, Gyimesi G, Ferdinandy P, Spadoni C, Darvas F, Fujita T, Ürge L, Dormán G.
Enhanced hit-to-lead process using bioanalogous lead evolution and chemogenomics: application in designing selective matrix metalloprotease inhibitors.
Expert Opin Drug Discov 2:707-723 (2007)

Csont T, Bereczki E, Bencsik P, Fodor G, Gorbe A, Zvara A, Csonka C, Puskas LG, Santha M, Ferdinandy P.
Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice.
Cardiovasc Res. 76:100-109 (2007)

Dormán G, Kocsis-Szommer K, Spadoni C, Ferdinandy P.
MMP inhibitors in cardiac diseases: an update.
Recent Patents Cardiovasc Drug Discov 2:186-194 (2007)

Ferdinandy P, Schulz R, Baxter GF.
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning and postconditioning.
Pharmacol Rev 59:418-458 (2007)

2006

Giricz Z, Lalu MM, Csonka C, Bencsik P, Schulz R, Ferdinandy P.
Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition.
J Pharmacol Exp Ther 316:154-61(2006)

Konya C, Ferdinandy P.
Vitamin C: new role of the old vitamin in the cardiovascular system.
Br J Pharmacol 147:125-127 (2006)

Turan N, Csonka C, Csont T, Giricz Z, Fodor G, Bencsik P, Gyongyosi M, Cakici I, Ferdinandy P.
The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts.
Cardiovasc Res 70:384-390 (2006)

Ferdinandy P.
Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well?
Br J Pharmacol 148:1-3 (2006)

2005

Ungi I, Ungi T, Ruzsa Z, Nagy E, Zimmermann Z, Csont T, Ferdinandy P.
Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty.
Chest 128:1623-1628 (2005)